TSS:Rfhg 186456.1

Basic information about the TSS

---

TSS ID: rfhg_186456.1 Species: human Chr: chr16		Start: 75647325 End: 75647334 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D2883986,EH38E1828399)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK307901:403 GeneID: 54386 HGNC/MGI_ID: HGNC:19246 UniProt_ID: Nearer transcript ids and distances:

Gene_name: KARS Gene_symbol: TERF2IP Gene_synonyms: RAP1 Gene_source: HGNC:19246

TATA-Box annotation

---

Distance to TSS:	358
Nearest PromoterID:	NM_001130089
Entrez ID:	3735
Nearest Unigene:	Hs.3100
Nearest Refseq:	NM_005548
Nearest Ensembl:	ENSG00000065427
Gene Name:	KARS
Gene Alias:	CMTRIB|DFNB89|KARS1|KARS2|KRS
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TERF2IP p2@TERF2IP p3@TERF2IP
Sample		p1@TERF2IP	p2@TERF2IP	p3@TERF2IP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	39.93	22.01	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	40.87	25.09	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	47.07	17.55	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	46.36	17.88	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	48.14	20.70	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	42.83	14.54	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.71	26.36	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	42.39	16.96	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.32	20.73	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	62.02	26.08	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	49.72	23.45	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	54.48	24.80	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.67	13.54	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.67	12.33	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	12.73	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.81	14.08	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.48	14.85	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.12	16.03	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	11.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.43	12.64	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.63	12.70	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.95	14.33	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.57	11.25	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.71	18.44	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	14.45	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	14.56	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	14.29	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	8.96	11.79	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.38	12.44	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.12	9.05	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.63	11.30	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.18	10.55	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.82	12.45	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	10.39	12.87	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.78	10.85	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.07	12.46	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.63	7.15	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.68	9.47	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.64	10.53	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	9.36	8.88	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.94	9.65	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.49	12.74	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.80	8.65	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.87	9.97	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.64	10.84	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.93	13.49	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.84	10.08	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	11.92	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.81	11.01	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.68	10.31	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.81	11.48	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.57	13.79	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	55.97	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	10.65	12.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.94	13.26	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	15.10	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.02	11.94	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.29	10.05	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	13.81	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.94	19.17	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	9.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	8.97	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	9.55	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	11.89	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.37	6.82	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.13	10.65	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	55.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	9.75	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	14.38	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	7.97	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	20.53	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.63	13.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.12	10.70	0.61
Adipocyte - breast, donor1	11376-118A8	20.27	17.26	0.63
Adipocyte - breast, donor2	11327-117E4	21.02	15.56	1.28
Adipocyte - omental, donor1	11473-119C6	20.23	23.41	1.27
Adipocyte - omental, donor2	11474-119C7	17.19	17.94	1.49
Adipocyte - omental, donor3	11475-119C8	15.41	15.74	1.34
Adipocyte - perirenal, donor1	11476-119C9	13.40	24.24	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	7.70	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	29.36	11.29	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	24.15	19.46	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	25.62	17.21	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	11.58	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	32.90	13.38	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	27.04	22.34	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	31.69	22.60	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	21.62	16.78	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	12.26	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.14	22.81	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	19.13	18.30	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	20.60	16.07	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	22.58	20.62	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	18.57	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	17.02	13.92	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	6.10	3.94	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	11.98	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	16.19	17.81	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	18.41	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	17.87	17.46	1.03
Anulus Pulposus Cell, donor1	11248-116E6	35.13	35.93	1.95
Anulus Pulposus Cell, donor2	11463-119B5	24.98	21.80	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.62	9.88	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	14.76	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	23.54	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.81	14.35	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	35.41	20.23	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	9.90	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.77	16.24	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	14.56	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	14.25	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.08	17.33	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	15.96	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	8.78	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.68	19.60	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	21.84	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.47	16.44	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	17.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.35	14.36	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.12	16.84	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	9.75	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.72	11.11	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	16.81	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	17.70	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.07	15.09	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	26.70	14.56	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	17.08	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	12.11	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.23	14.25	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.80	15.39	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.00	13.94	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.05	16.42	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.15	17.36	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	9.99	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	11.11	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.98	12.65	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	16.63	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.46	16.27	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.12	14.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	16.52	12.71	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.42	12.51	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	22.44	13.97	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.59	12.18	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	23.62	17.95	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.94	15.60	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	21.13	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	17.37	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.88	15.64	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	12.39	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.42	16.32	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	15.30	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	36.10	17.29	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.09	15.69	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	15.30	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	37.76	15.77	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.27	14.86	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	36.62	10.68	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.25	13.29	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	33.63	20.92	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	23.62	10.54	0.00
Astrocyte - cerebellum, donor1	11500-119F6	58.58	34.27	2.82
Astrocyte - cerebellum, donor2	11580-120F5	27.39	24.65	1.88
Astrocyte - cerebellum, donor3	11661-122F5	45.93	19.09	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	44.62	38.00	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	38.02	22.81	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	38.78	29.98	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	63.19	51.84	2.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	67.53	46.86	2.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	58.61	49.62	2.05
Basophils, donor1	12241-129G9	41.32	18.31	0.26
Basophils, donor2	12242-129H1	94.17	15.87	0.36
Basophils, donor3	12243-129H2	31.02	11.91	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	15.09	12.07	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	5.49	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.79	6.90	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	5.61	6.03	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	10.13	5.76	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	14.22	14.22	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	67.71	43.59	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	65.45	41.22	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.17	36.45	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	27.05	14.65	0.00
CD14+ Monocytes, donor2	11305-117B9	31.92	14.29	0.19
CD14+ Monocytes, donor3	11381-118B4	35.56	16.47	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.04	32.55	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.50	28.05	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	20.38	28.93	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	24.86	27.03	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	17.80	15.39	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	24.64	23.93	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.05	11.89	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.84	8.56	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.36	9.17	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.66	10.96	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.64	11.40	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.59	18.72	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.75	15.22	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.42	22.18	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	18.86	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.36	14.87	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.16	11.37	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.49	24.78	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.01	12.81	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.13	12.44	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.95	14.84	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.82	17.22	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.02	11.69	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	20.62	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.10	7.72	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.27	4.93	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.36	13.16	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.39	10.99	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	17.84	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.18	19.61	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	15.56	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.60	12.29	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.99	14.38	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	23.10	31.60	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	24.25	27.26	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	20.36	30.54	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	32.70	48.74	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	29.17	39.47	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	25.64	42.36	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	32.15	40.57	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	35.35	40.40	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	33.90	44.21	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	54.87	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	73.22	54.24	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	75.60	65.24	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	73.03	60.77	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	76.12	50.39	4.29
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	54.75	51.24	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.12	51.77	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	64.60	55.37	2.64
CD19+ B Cells, donor1	11544-120B5	86.30	70.68	1.64
CD19+ B Cells, donor2	11624-122B4	72.54	41.35	0.00
CD19+ B Cells, donor3	11705-123B4	84.81	41.40	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	391.53	330.52	19.39
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	331.58	248.48	17.58
CD34+ Progenitors, donor1	11545-120B6	33.13	32.13	2.01
CD34+ Progenitors, donor2	11625-122B5	42.14	16.29	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	47.35	24.80	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	41.26	29.31	1.80
CD4+ T Cells, donor1	11225-116C1	137.82	42.49	1.43
CD4+ T Cells, donor2	11306-117C1	127.98	33.68	0.61
CD4+ T Cells, donor3	11382-118B5	117.42	41.78	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	65.85	57.43	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	77.49	55.70	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	75.03	67.84	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	129.43	73.96	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	170.66	104.65	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	121.96	102.18	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	94.08	47.40	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	81.00	39.99	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	81.41	41.59	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	159.15	64.55	4.03
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	167.01	82.46	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	153.99	79.64	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.15	56.08	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	79.99	48.83	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	58.14	45.11	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	134.06	87.02	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	134.52	82.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	109.39	107.59	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	88.45	52.85	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	92.06	41.59	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	94.78	41.40	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	130.95	45.50	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	147.31	59.79	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	128.13	58.40	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	145.00	67.30	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	152.33	68.32	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	160.52	58.62	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	121.57	57.05	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	138.65	72.64	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	154.00	72.38	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	127.13	55.87	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	199.44	58.17	0.00
CD8+ T Cells, donor1	11226-116C2	171.56	18.01	0.00
CD8+ T Cells, donor2	11307-117C2	162.94	12.01	0.00
CD8+ T Cells, donor3	11383-118B6	154.27	24.24	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.68	19.73	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.48	19.65	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.77	14.77	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.15	21.01	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	71.27	14.40	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	48.43	9.55	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	66.49	11.52	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	62.91	16.85	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	65.20	19.23	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	73.05	16.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	60.13	14.82	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	65.54	15.45	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	85.80	14.45	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	91.09	20.04	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	52.96	12.68	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.11	14.41	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	61.57	16.11	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	54.68	15.08	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	70.35	16.48	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	74.43	15.07	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	66.68	16.35	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.08	16.83	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	70.54	16.16	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	70.35	14.37	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	166.21	37.74	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	155.97	41.27	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	196.34	53.09	0.00
Cardiac Myocyte, donor1	11525-119I4	21.93	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	21.25	14.33	0.99
Cardiac Myocyte, donor3	11686-122I3	17.68	16.52	1.26
Chondrocyte - de diff, donor1	11261-116G1	27.73	18.37	1.04
Chondrocyte - de diff, donor2	11338-117F6	25.94	16.70	2.13
Chondrocyte - de diff, donor3	11410-118E6	34.36	24.12	1.48
Chondrocyte - re diff, donor2	11339-117F7	51.03	25.07	0.90
Chondrocyte - re diff, donor3	11411-118E7	33.57	17.39	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	37.41	33.05	2.41
Ciliary Epithelial Cells, donor2	11323-117D9	33.77	19.45	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	35.31	21.59	1.86
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	70.33	79.69	7.52
Corneal Epithelial Cells, donor1	11526-119I5	10.54	12.95	0.66
Corneal Epithelial Cells, donor2	11606-120I4	20.48	18.20	2.28
Corneal Epithelial Cells, donor3	11687-122I4	9.46	9.20	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.87	14.36	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.12	15.46	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.18	16.20	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	88.14	20.16	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	66.59	20.24	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	92.43	25.17	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	14.51	11.34	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	9.39	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	21.21	12.16	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	11.40	15.33	0.39
Endothelial Cells - Artery, donor1	11264-116G4	20.36	9.60	0.87
Endothelial Cells - Artery, donor2	11341-117F9	22.12	12.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	17.00	10.52	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.51	14.63	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.73	14.60	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.32	23.12	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	22.29	16.64	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	23.43	9.89	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	21.55	18.01	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	24.41	16.81	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	13.63	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	21.37	22.61	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.12	13.69	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.56	18.32	1.95
Endothelial Cells - Vein, donor1	11267-116G7	9.10	5.69	1.14
Endothelial Cells - Vein, donor2	11344-117G3	18.86	9.08	1.40
Endothelial Cells - Vein, donor3	11416-118F3	13.97	14.29	0.94
Eosinophils, donor1	12244-129H3	60.99	60.99	0.00
Eosinophils, donor2	12245-129H4	69.31	87.46	3.30
Eosinophils, donor3	12246-129H5	67.77	67.77	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.95	9.77	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	14.56	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.06	18.47	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.44	9.96	1.09
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.18	18.20	1.84
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.17	21.59	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.71	20.33	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.94	18.67	1.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.51	19.50	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	26.91	17.94	2.33
Fibroblast - Cardiac, donor1	11268-116G8	21.32	16.33	0.91
Fibroblast - Cardiac, donor2	11345-117G4	23.50	9.10	0.76
Fibroblast - Cardiac, donor3	11417-118F4	18.93	11.51	0.95
Fibroblast - Cardiac, donor4	11452-119A3	21.52	25.46	1.82
Fibroblast - Cardiac, donor5	11456-119A7	20.30	18.65	1.27
Fibroblast - Cardiac, donor6	11460-119B2	13.80	14.55	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	44.75	31.35	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.32	25.89	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	23.44	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	65.04	34.60	2.31
Fibroblast - Conjunctival, donor3	11692-122I9	31.38	35.79	2.71
Fibroblast - Dermal, donor1	11269-116G9	27.00	12.91	0.94
Fibroblast - Dermal, donor2	11346-117G5	23.58	15.57	0.94
Fibroblast - Dermal, donor3	11418-118F5	22.24	14.87	0.36
Fibroblast - Dermal, donor4	11450-119A1	17.97	16.62	2.37
Fibroblast - Dermal, donor5	11454-119A5	17.62	16.22	0.70
Fibroblast - Dermal, donor6	11458-119A9	19.00	15.92	0.81
Fibroblast - Gingival, donor1	11237-116D4	24.99	17.91	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	23.32	2.10
Fibroblast - Gingival, donor2	11318-117D4	18.58	18.58	1.58
Fibroblast - Gingival, donor3	11394-118C8	30.94	23.98	1.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	19.74	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	22.55	20.62	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.51	14.97	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.05	20.69	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	17.64	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	26.76	21.64	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.45	22.23	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	19.20	13.16	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.00	25.24	1.17
Fibroblast - Lung, donor1	11270-116H1	9.52	8.16	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	23.87	1.49
Fibroblast - Lung, donor3	11419-118F6	20.26	17.09	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	37.49	26.66	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	25.18	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	10.92	7.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	32.88	21.11	1.62
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.79	21.92	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.21	24.88	2.12
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.56	17.75	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.95	14.50	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.30	20.79	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.93	18.09	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.79	14.92	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	19.91	18.69	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	18.04	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.84	10.28	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.71	17.26	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.22	20.25	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.44	17.54	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	25.87	16.25	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.37	17.81	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	41.00	30.12	0.76
Fibroblast - skin normal, donor1	11553-120C5	25.92	22.31	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.87	14.84	0.80
Fibroblast - skin normal, donor2	11561-120D4	23.51	21.30	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	39.90	27.81	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	25.02	19.30	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.79	27.18	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	41.05	16.75	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.77	20.56	1.70
Fibroblast - skin walker warburg, donor1	11554-120C6	28.17	23.11	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	20.70	16.31	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	66.48	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.07	14.82	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	16.47	15.95	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	14.57	14.57	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.56	12.01	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	11.48	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.93	8.93	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.56	11.98	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.24	25.65	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	25.80	20.55	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	5.35	9.51	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.04	15.60	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.50	18.59	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	12.38	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.70	18.37	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.17	20.44	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.48	10.48	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.11	19.58	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	10.52	15.23	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	6.91	11.59	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.25	16.89	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.20	16.94	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.43	11.80	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.91	17.73	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	19.23	24.16	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.97	16.76	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.45	29.44	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	30.20	31.55	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.39	18.71	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.19	38.60	1.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.69	36.55	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.54	27.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.80	23.13	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.97	27.36	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.77	29.30	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	29.17	35.63	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.01	19.68	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.73	25.79	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.99	37.27	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.72	24.96	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.56	35.60	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.61	27.95	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.61	21.51	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	32.23	29.19	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.11	30.42	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.08	24.59	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	34.79	32.82	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.55	17.13	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.46	18.18	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.38	21.27	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.90	19.82	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.58	20.06	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.94	20.65	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.22	28.29	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	34.71	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	28.89	21.63	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.42	20.78	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.06	34.31	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.76	13.34	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.01	12.94	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	8.39	18.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.76	7.82	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.89	11.02	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.38	12.91	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.67	11.99	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	14.44	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	15.65	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.34	10.74	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	18.12	13.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.26	14.54	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.00	14.05	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	11.74	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.85	14.00	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.70	7.81	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	12.53	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.19	25.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.67	17.17	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	8.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	28.99	20.30	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	27.85	13.35	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.45	16.53	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	34.55	16.95	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	34.11	19.40	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	46.23	34.29	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.26	21.23	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	29.82	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.84	36.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	39.23	35.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.94	20.86	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.51	29.12	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	39.96	28.12	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	34.23	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	37.92	34.42	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	31.16	45.20	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	43.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	41.19	17.31	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	18.92	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	11.41	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.11	13.31	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	14.62	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.79	24.74	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.62	15.04	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.68	19.38	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.32	22.45	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.70	18.88	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.88	20.00	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.77	26.22	3.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.51	21.31	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	14.82	16.19	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	20.07	17.50	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.94	17.30	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	15.67	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.71	10.82	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	13.22	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.87	22.57	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	14.53	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.46	10.67	0.70
Hepatocyte, donor1	11523-119I2	32.69	18.16	1.21
Hepatocyte, donor2	11603-120I1	30.17	23.70	0.00
Hepatocyte, donor3	11684-122I1	28.84	22.70	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	106.39	50.91	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.67	21.15	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.66	15.64	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	15.92	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	20.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	20.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	22.52	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	47.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	12.81	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	41.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	32.49	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	26.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	21.78	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	27.79	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	11.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	31.43	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.27	27.08	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	21.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	30.36	17.44	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	17.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	25.26	21.19	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	20.57	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.93	21.70	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	21.24	11.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.52	22.66	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	12.70	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	26.90	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	22.87	21.60	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	15.30	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	18.23	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	17.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	23.23	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	24.69	22.53	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	26.34	22.83	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	22.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	17.38	22.25	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	15.49	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	12.21	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	11.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	13.94	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	17.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	11.08	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	19.95	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	20.25	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	31.04	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	14.80	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.81	13.55	0.82
Keratinocyte - epidermal, donor2	11349-117G8	16.98	9.37	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.06	12.49	0.66
Keratinocyte - oral, donor1	11251-116E9	19.07	26.45	1.48
Keratocytes, donor1	11527-119I6	56.04	33.70	1.38
Keratocytes, donor2	11607-120I5	21.09	14.06	1.17
Keratocytes, donor3	11688-122I5	26.08	20.95	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	13.19	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	21.57	1.08
Lens Epithelial Cells, donor2	11609-120I7	42.44	28.95	1.27
Lens Epithelial Cells, donor3	11690-122I7	42.89	28.86	1.31
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.12	16.84	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	20.65	14.51	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	35.26	18.10	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.81	12.91	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	17.33	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	22.53	15.63	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	24.21	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.95	13.15	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.13	14.92	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	27.29	20.96	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	26.56	18.81	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.89	14.26	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	29.27	19.16	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.85	17.65	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.76	14.70	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.10	16.01	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	17.15	10.60	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	23.24	19.40	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.58	21.39	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.43	14.06	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.92	11.45	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.19	18.91	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.62	23.16	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	20.44	14.08	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	31.62	19.70	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.01	17.17	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.60	13.08	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	15.13	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.40	17.31	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.99	14.53	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	22.29	17.44	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.16	13.23	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.69	13.50	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	18.14	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	22.73	21.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.64	13.20	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	30.88	17.69	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.09	19.78	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.61	21.27	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.51	20.27	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	20.85	14.54	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.18	13.07	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	18.62	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.48	11.76	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.78	13.18	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	23.02	17.08	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.09	12.81	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.08	12.83	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	15.86	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	26.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	26.72	32.66	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	34.27	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	22.51	25.32	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	22.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.19	29.37	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	27.36	20.22	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.10	30.54	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.96	36.35	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	40.52	45.47	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.56	36.72	2.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	27.22	38.00	4.62
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.05	39.17	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	36.65	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	35.15	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.15	38.42	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.11	37.60	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.61	42.34	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	39.14	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	39.98	43.73	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	31.39	40.92	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	31.94	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.09	38.61	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	29.59	32.58	3.89
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.96	32.64	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.93	28.28	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	31.72	32.45	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	25.33	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	39.91	38.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	31.70	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	22.97	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.40	31.18	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.16	34.47	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	34.36	29.88	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	30.47	36.79	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.91	47.81	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	25.69	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.32	39.98	4.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	41.63	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.13	23.46	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.28	30.93	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	29.52	40.79	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.32	23.57	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.89	39.63	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	31.40	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	29.62	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.61	35.21	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	24.71	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	25.30	23.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	27.13	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	31.05	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.65	29.16	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.69	28.39	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	24.10	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.04	28.06	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	35.19	30.89	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	28.37	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	24.39	30.10	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	30.63	38.51	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.40	36.34	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	29.59	33.12	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.80	34.71	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.87	52.66	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.12	40.85	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.01	39.36	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	34.63	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	30.43	26.28	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.20	38.38	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.73	29.95	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	31.44	24.79	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.71	32.64	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	38.38	29.32	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.01	21.84	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	39.08	27.77	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	31.83	34.66	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	35.75	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.11	32.03	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	33.67	32.10	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.90	25.05	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.88	33.45	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	32.78	26.09	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.01	25.66	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.18	38.39	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	32.12	22.03	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	38.23	25.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	32.48	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.84	32.21	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	36.11	28.45	4.38
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	28.95	24.05	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.01	35.87	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	27.19	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	29.10	8.31
Macrophage - monocyte derived, donor1	11232-116C8	12.99	21.42	1.60
Macrophage - monocyte derived, donor2	11313-117C8	22.94	17.62	0.73
Macrophage - monocyte derived, donor3	11389-118C3	19.53	15.21	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.71	16.46	0.00
Mallassez-derived cells, donor2	11929-125I3	21.87	20.92	0.63
Mallassez-derived cells, donor3	11930-125I4	20.29	15.71	0.69
Mammary Epithelial Cell, donor1	11273-116H4	37.67	24.61	1.49
Mammary Epithelial Cell, donor2	11350-117G9	34.75	21.43	1.74
Mammary Epithelial Cell, donor3	11422-118F9	9.98	7.73	0.75
Mast cell - stimulated, donor1	11487-119E2	145.08	50.85	0.68
Mast cell, donor1	11563-120D6	98.73	44.45	2.27
Mast cell, donor2	11565-120D8	60.62	68.65	4.16
Mast cell, donor3	11566-120D9	71.36	93.88	4.50
Mast cell, donor4	11567-120E1	53.01	64.00	3.37
Mast cell, expanded and stimulated, donor5	11940-126A5	76.41	42.80	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	91.05	37.36	0.58
Mast cell, expanded, donor5	11939-126A4	49.79	52.66	1.61
Mast cell, expanded, donor8	11941-126A6	68.12	44.69	1.51
Melanocyte - dark, donor1	11502-119F8	24.08	19.20	1.09
Melanocyte - dark, donor2	11582-120F7	24.92	19.73	0.69
Melanocyte - dark, donor3	11663-122F7	38.97	25.79	1.23
Melanocyte - light, donor1	11274-116H5	21.86	8.93	0.24
Melanocyte - light, donor2	11351-117H1	17.74	15.01	0.68
Melanocyte - light, donor3	11423-118G1	8.67	10.41	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	27.49	27.28	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	27.43	21.78	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	35.89	30.00	2.14
Meningeal Cells, donor1	11493-119E8	26.92	26.80	1.86
Meningeal Cells, donor2	11573-120E7	20.69	22.45	0.88
Meningeal Cells, donor3	11654-122E7	21.43	21.19	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	20.82	23.38	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.77	17.31	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	10.51	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	6.54	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	15.79	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.35	23.08	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.63	18.10	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	22.20	17.58	2.64
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	13.88	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.60	14.32	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.75	22.72	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.59	18.96	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.87	28.95	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.37	17.51	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	18.57	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.62	16.66	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.20	28.46	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	14.51	0.00
Mesothelial Cells, donor1	11247-116E5	24.93	20.95	1.06
Mesothelial Cells, donor2	12156-128G5	20.02	18.02	1.50
Mesothelial Cells, donor3	11402-118D7	20.60	17.99	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	10.80	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.37	11.33	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.96	14.72	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	11.16	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.29	14.52	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	6.95	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.52	15.52	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.27	11.64	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	22.96	14.02	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	18.61	15.84	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	7.96	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	24.32	18.24	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.13	9.55	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	6.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	11.33	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	20.82	12.80	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.68	13.55	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.79	10.59	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.14	11.78	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.75	7.95	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.45	10.30	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	22.01	9.78	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.71	10.07	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	11.15	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	7.61	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.35	10.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	7.63	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	10.57	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.41	10.01	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	26.03	10.51	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	30.65	17.52	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	3.20	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	29.50	15.37	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	6.96	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.96	12.65	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	8.75	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.14	7.10	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	26.37	16.55	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.52	5.82	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.74	4.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	10.26	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.06	14.61	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	16.62	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	32.44	10.24	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.21	11.47	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	23.32	15.81	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.03	14.16	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	6.35	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.35	15.21	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.44	21.55	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.42	12.15	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	25.16	17.84	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.81	18.57	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	10.62	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.58	19.04	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	35.89	21.88	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	7.82	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.52	14.11	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.29	21.91	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.20	22.26	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	22.04	17.57	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	15.11	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	10.52	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.64	21.35	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	26.08	22.35	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.89	18.40	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	13.85	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.59	14.14	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	13.26	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.66	11.36	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	15.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.02	5.88	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	13.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.65	8.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	13.62	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	6.99	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	5.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	13.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	57.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	26.10	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	75.29	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.47	20.25	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	17.77	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.68	10.68	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.69	3.34	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.73	15.02	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	12.77	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	4.08	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	31.24	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.81	8.37	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.64	10.69	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.70	7.57	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.77	13.67	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	33.40	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.87	10.42	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.89	11.37	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.73	10.65	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	13.55	10.29	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.86	12.76	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	13.26	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	7.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.05	17.72	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	9.43	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.40	16.93	1.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	11.25	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.90	9.19	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	10.93	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.18	15.18	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	35.40	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.94	15.82	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	9.31	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.92	15.43	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	26.61	12.88	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	63.19	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.33	12.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.74	8.57	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	12.30	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	7.43	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	14.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.95	11.73	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	10.46	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	15.38	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	10.58	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	16.62	14.63	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	19.84	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.78	6.51	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.94	30.85	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.96	17.90	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	9.49	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	76.64	20.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	16.46	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.68	11.33	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	12.71	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	4.75	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5.67	23.81	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	45.52	0.00
Myoblast, donor1	11241-116D8	29.19	15.40	0.87
Myoblast, donor2	11322-117D8	28.96	18.80	1.34
Myoblast, donor3	11398-118D3	26.40	14.63	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	91.94	34.29	0.73
Natural Killer Cells, donor1	11230-116C6	141.15	19.37	0.62
Natural Killer Cells, donor2	11311-117C6	129.07	20.81	0.00
Natural Killer Cells, donor3	11387-118C1	133.26	17.85	0.00
Neural stem cells, donor1	11275-116H6	98.36	41.38	1.45
Neural stem cells, donor2	11352-117H2	179.08	130.94	5.78
Neurons, donor1	11494-119E9	187.75	86.48	10.24
Neurons, donor2	11574-120E8	142.01	92.69	3.52
Neurons, donor3	11655-122E8	112.64	46.04	4.93
Neutrophils, donor1	11233-116C9	44.54	61.25	0.00
Neutrophils, donor2	11314-117C9	46.38	86.97	2.90
Neutrophils, donor3	11390-118C4	43.98	83.07	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	38.95	37.88	2.02
Nucleus Pulposus Cell, donor2	11409-118E5	21.82	26.70	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	19.25	21.66	1.60
Olfactory epithelial cells, donor1	11933-125I7	10.87	16.11	1.51
Olfactory epithelial cells, donor2	11934-125I8	14.91	12.88	0.87
Olfactory epithelial cells, donor3	11935-125I9	14.53	15.21	0.79
Olfactory epithelial cells, donor4	11936-126A1	13.93	18.90	1.36
Oligodendrocyte - precursors, donor1	11496-119F2	23.47	14.44	1.20
Osteoblast - differentiated, donor1	11276-116H7	15.31	14.89	0.21
Osteoblast - differentiated, donor2	11353-117H3	21.72	11.43	2.29
Osteoblast - differentiated, donor3	11425-118G3	18.62	19.24	0.62
Osteoblast, donor1	11277-116H8	31.86	23.26	1.37
Osteoblast, donor2	11354-117H4	49.86	25.28	2.11
Osteoblast, donor3	11426-118G4	28.26	21.15	0.71
Pancreatic stromal cells, donor1	11249-116E7	29.57	22.15	1.68
Pericytes, donor1	11491-119E6	19.14	17.02	1.78
Pericytes, donor2	11571-120E5	23.54	20.37	2.04
Pericytes, donor3	11652-122E5	15.87	14.24	0.61
Perineurial Cells, donor1	11499-119F5	27.35	19.67	1.13
Perineurial Cells, donor2	11579-120F4	25.86	20.43	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	96.90	50.36	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	59.50	35.26	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	87.61	38.95	0.78
Placental Epithelial Cells, donor1	11278-116H9	16.74	14.11	0.48
Placental Epithelial Cells, donor2	11355-117H5	9.98	14.42	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.62	10.21	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.57	11.08	0.95
Preadipocyte - breast, donor1	11467-119B9	21.38	22.14	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.63	25.97	0.39
Preadipocyte - breast, donor2	11328-117E5	27.92	22.06	2.48
Preadipocyte - omental, donor1	11468-119C1	20.46	20.67	1.60
Preadipocyte - omental, donor2	11329-117E6	20.95	23.13	2.18
Preadipocyte - omental, donor3	11403-118D8	33.81	25.07	2.15
Preadipocyte - perirenal, donor1	11469-119C2	10.83	13.78	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	25.18	9.52	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	31.34	18.95	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	36.44	18.05	1.87
Preadipocyte - visceral, donor1	11280-116I2	29.34	18.63	1.49
Preadipocyte - visceral, donor2	11357-117H7	42.34	33.13	1.84
Preadipocyte - visceral, donor3	11429-118G7	26.44	15.67	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.59	16.90	0.45
Prostate Epithelial Cells, donor2	11331-117E8	15.57	15.71	1.08
Prostate Epithelial Cells, donor3	11404-118D9	13.41	11.45	0.73
Prostate Stromal Cells, donor1	11254-116F3	30.41	15.38	1.03
Prostate Stromal Cells, donor2	11332-117E9	30.84	24.74	1.61
Prostate Stromal Cells, donor3	11405-118E1	25.55	17.41	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.60	20.80	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	13.86	20.93	0.90
Renal Epithelial Cells, donor1	11517-119H5	8.62	11.67	1.01
Renal Epithelial Cells, donor2	11597-120H4	7.82	14.23	1.42
Renal Epithelial Cells, donor3	11678-122H4	15.24	21.38	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	13.62	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.85	11.59	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.98	17.09	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	12.64	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.15	18.93	0.88
Renal Mesangial Cells, donor2	11598-120H5	19.44	25.71	2.51
Renal Mesangial Cells, donor3	11679-122H5	9.43	8.60	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	20.67	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	14.34	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.87	12.34	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.41	32.41	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.00	28.99	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	6.17	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	27.10	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.12	43.03	4.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	29.48	16.08	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	51.18	29.17	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	60.33	38.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	37.45	20.41	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	39.03	19.76	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	45.95	22.75	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	62.15	26.42	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	40.67	17.95	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	41.83	22.42	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	40.80	13.55	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.89	17.09	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	37.99	20.97	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	42.75	16.78	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.66	23.72	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.17	20.14	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.00	11.28	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.53	16.77	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.59	27.62	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.12	11.94	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	35.72	19.66	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	37.43	23.68	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	38.23	15.91	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.56	21.02	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.43	18.29	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	35.19	14.04	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	35.07	17.41	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.91	19.75	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	54.25	17.93	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	37.70	17.66	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.73	20.81	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	51.01	16.80	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	32.96	19.69	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.00	16.29	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	50.33	17.09	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	37.64	15.84	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	39.33	19.28	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	50.21	18.40	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.81	21.26	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	39.56	24.95	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.45	13.46	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	45.13	20.71	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.98	22.12	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	51.99	21.85	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.81	23.57	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	43.94	29.63	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.85	24.20	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	53.10	29.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.71	20.25	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.00	17.99	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	50.36	29.11	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	48.67	18.25	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.33	15.97	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.43	27.14	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	52.12	32.65	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.15	21.73	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	47.81	19.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	33.65	25.84	1.20
Schwann Cells, donor1	11498-119F4	12.98	15.80	0.94
Schwann Cells, donor2	11578-120F3	17.01	10.21	3.40
Schwann Cells, donor3	11659-122F3	19.94	20.16	2.19
Sebocyte, donor1	11220-116B5	26.84	16.98	0.55
Sebocyte, donor2	11301-117B5	11.03	8.27	0.46
Sebocyte, donor3	11378-118B1	20.82	14.84	0.62
Sertoli Cells, donor1	11255-116F4	29.82	29.82	1.66
Sertoli Cells, donor2	11333-117F1	14.12	28.24	2.82
Skeletal Muscle Cells, donor1	11281-116I3	30.70	21.47	1.32
Skeletal Muscle Cells, donor2	11358-117H8	16.63	9.40	0.72
Skeletal Muscle Cells, donor3	11430-118G8	17.56	14.21	1.67
Skeletal Muscle Cells, donor4	11451-119A2	20.27	15.55	0.79
Skeletal Muscle Cells, donor5	11455-119A6	16.80	15.61	1.49
Skeletal Muscle Cells, donor6	11459-119B1	18.16	14.01	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.23	23.19	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.69	17.55	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	23.22	14.88	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	42.46	21.15	1.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	13.75	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.13	12.80	0.55
Skin - palm, donor1	10286-104F7	24.17	37.61	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.69	9.23	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.08	20.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.00	7.66	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	17.93	12.79	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	16.60	7.17	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	24.10	17.97	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	18.44	11.54	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	39.81	12.65	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	32.24	17.34	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	11.17	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.66	13.92	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	39.38	16.14	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	19.31	20.09	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	20.02	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	33.27	18.23	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	35.91	19.06	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	28.93	15.62	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.58	15.63	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.92	23.63	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.09	17.94	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	15.62	12.69	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.87	16.13	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.74	12.63	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	18.36	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	10.01	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.11	17.11	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.99	13.13	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.11	16.90	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.98	11.29	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	10.78	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.92	15.24	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.92	11.61	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.12	19.63	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.47	19.32	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	48.70	19.34	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.13	12.08	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.35	20.66	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.30	21.84	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.45	24.54	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.00	10.91	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.17	18.70	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	22.51	18.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.51	16.74	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	30.29	24.23	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.64	15.04	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.35	13.27	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.99	17.74	1.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	13.55	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	35.84	19.00	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.99	14.79	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.24	13.35	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	24.46	18.59	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.65	23.54	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	11.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.93	15.41	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.91	18.56	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.24	7.31	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.85	20.99	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.74	14.28	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	26.78	17.85	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	23.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.14	18.74	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.00	18.91	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	17.01	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	28.35	20.76	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	16.30	14.21	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	15.58	1.38
Synoviocyte, donor1	11291-117A4	35.18	21.38	1.18
Synoviocyte, donor2	11368-117I9	32.85	25.98	0.50
Synoviocyte, donor3	11440-118H9	15.86	23.46	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	19.65	20.73	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	7.93	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	18.06	15.51	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	14.48	10.82	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	5.80	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	2.86	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	24.11	40.60	2.34
Urethra, donor2	10319-105A4	16.19	26.98	3.60
Urothelial Cells, donor1	11520-119H8	15.14	7.97	1.06
Urothelial Cells, donor2	11600-120H7	8.41	9.21	0.80
Urothelial Cells, donor3	11681-122H7	6.19	8.02	0.23
Urothelial cells, donor0	11216-116B1	19.17	23.40	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	97.88	123.68	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	110.08	121.52	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	63.66	91.04	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.41	54.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	48.81	61.01	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	89.55	104.12	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	97.29	121.15	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	68.47	68.47	6.39
Wilms' tumor cell line:G-401	10809-111A8	25.54	10.86	0.49
Wilms' tumor cell line:HFWT	10597-108E3	14.96	9.68	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.42	18.43	0.84
achilles tendon, donor2	10292-104G4	8.27	6.20	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	27.03	27.28	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.03	42.49	2.55
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	90.57	53.54	2.97
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	84.36	45.17	3.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	60.43	32.04	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	38.70	30.03	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	58.25	32.94	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.69	14.54	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.37	20.83	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.96	20.97	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	40.66	31.28	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	15.60	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.73	28.58	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	59.55	30.55	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	46.76	32.15	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.38	22.31	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.84	20.15	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.81	8.59	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	24.32	25.18	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.62	18.50	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.20	23.83	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.51	20.49	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	37.69	28.02	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	29.73	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.73	19.59	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	66.29	25.73	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	15.31	12.48	0.47
adipose tissue, adult, pool1	10010-101C1	22.80	43.74	2.95
adipose, donor1	10184-103D4	19.94	28.15	1.17
adipose, donor2	10185-103D5	24.33	25.95	1.62
adipose, donor3	10186-103D6	27.50	22.33	0.82
adipose, donor4	10187-103D7	6.07	8.67	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.67	19.25	2.68
adrenal gland, adult, pool1	10081-102A9	36.38	25.46	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.01	33.22	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	32.16	11.43	0.36
amniotic membrane cells, donor1	12235-129G3	24.81	22.03	1.39
amniotic membrane cells, donor2	12236-129G4	15.55	33.13	2.37
amniotic membrane cells, donor3	12237-129G5	17.68	33.00	2.95
amygdala - adult, donor10196	10167-103B5	249.02	130.44	11.86
amygdala, adult, donor10252	10151-102I7	137.68	122.27	9.12
amygdala, newborn, donor10223	10360-105E9	116.20	82.95	6.46
anaplastic carcinoma cell line:8305C	10428-106D5	24.19	34.25	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	14.12	6.84	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.07	34.07	1.67
aorta, adult, pool1	10052-101G7	24.71	44.13	3.14
appendix, adult	10189-103D9	45.80	37.26	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	53.65	46.43	3.10
artery, adult	10190-103E1	16.30	63.86	4.08
astrocytoma cell line:TM-31	10425-106D2	32.45	20.86	0.29
b cell line:RPMI1788	10427-106D4	58.89	42.68	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.24	18.31	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.63	8.34	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	16.74	16.91	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.88	15.10	0.00
bladder, adult, pool1	10011-101C2	28.79	48.89	2.93
blood, adult, pool1	10053-101G8	28.79	35.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	6.85	0.86
bone marrow, adult	10192-103E3	43.19	48.59	2.70
brain, adult, donor1	10084-102B3	109.68	88.16	8.20
brain, adult, pool1	10012-101C3	164.25	127.06	10.36
brain, fetal, pool1	10085-102B4	184.33	109.53	8.01
breast carcinoma cell line:MCF7	10482-107A5	33.70	33.04	3.96
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.73	19.35	0.75
breast, adult, donor1	10080-102A8	20.83	26.52	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.47	24.14	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.65	38.96	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.40	21.64	2.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.00	24.69	2.18
carcinoid cell line:NCI-H1770	10703-109H1	31.50	59.24	2.82
carcinoid cell line:NCI-H727	10735-110B6	42.66	21.44	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	13.94	13.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	44.45	57.49	5.32
caudate nucleus - adult, donor10196	10177-103C6	183.06	108.22	11.51
caudate nucleus, adult, donor10252	10164-103B2	158.79	128.17	10.37
caudate nucleus, adult, donor10258	10379-105H1	206.32	162.00	12.23
caudate nucleus, newborn, donor10223	10354-105E3	113.90	80.21	5.13
cerebellum - adult, donor10196	10173-103C2	250.54	311.72	20.39
cerebellum, adult, donor10252	10166-103B4	207.75	270.94	12.17
cerebellum, adult, pool1	10083-102B2	130.04	133.15	6.90
cerebellum, newborn, donor10223	10357-105E6	161.08	92.16	0.00
cerebral meninges, adult	10188-103D8	158.60	121.53	7.82
cerebrospinal fluid, donor2	10294-104G6	24.85	21.20	1.46
cervical cancer cell line:D98-AH2	10552-107I3	29.76	27.17	0.86
cervical cancer cell line:ME-180	10553-107I4	27.84	17.57	0.33
cervix, adult, pool1	10013-101C4	25.09	59.42	5.67
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.87	14.49	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	6.59	14.79	1.37
choriocarcinoma cell line:SCH	10785-110H2	11.09	18.48	2.09
choriocarcinoma cell line:T3M-3	10618-108G6	4.27	4.27	0.95
chorionic membrane cells, donor1	12238-129G6	19.09	19.37	1.14
chorionic membrane cells, donor2	12239-129G7	25.35	21.48	1.29
chorionic membrane cells, donor3	12240-129G8	18.68	18.13	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	68.67	33.32	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.70	14.22	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.29	17.74	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	37.49	47.51	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	40.15	44.02	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	43.98	37.67	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	35.33	28.86	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.44	21.37	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.03	18.74	2.51
clear cell carcinoma cell line:TEN	10636-108I6	6.94	10.93	0.52
colon carcinoma cell line:CACO-2	10513-107D9	11.90	11.53	1.83
colon carcinoma cell line:COLO-320	10420-106C6	66.89	60.81	2.28
colon, adult, donor1	10082-102B1	11.90	16.66	1.19
colon, adult, pool1	10014-101C5	22.09	35.49	1.53
colon, fetal, donor1	10070-101I7	19.78	29.66	0.00
common myeloid progenitor CMP, donor1	12130-128D6	36.67	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	101.13	19.55	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	65.20	17.96	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	69.38	19.74	1.55
corpus callosum, adult, pool1	10042-101F6	134.44	118.74	8.96
cruciate ligament, donor2	10295-104G7	16.21	12.16	1.62
diaphragm, fetal, donor1	10069-101I6	18.46	28.89	1.61
diencephalon, adult	10193-103E4	151.19	100.08	7.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	43.86	28.47	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.80	22.31	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.66	22.63	2.17
ductus deferens, adult	10196-103E7	21.43	55.32	5.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	24.48	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	50.76	6.62
dura mater, adult, donor1	10041-101F5	29.24	48.31	4.21
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	63.07	33.31	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	39.98	36.25	4.01
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	9.25	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	24.82	17.56	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	15.13	8.64	0.62
embryonic pancreas cell line:2C6	10603-108E9	30.21	15.76	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	12.74	7.71	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.97	30.63	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.03	14.63	0.96
epidermoid carcinoma cell line:A431	10426-106D3	13.89	16.23	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.98	19.80	1.32
epididymis, adult	10197-103E8	28.88	51.07	3.98
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	53.76	22.35	3.55
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.16	11.80	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	29.88	34.99	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	30.41	21.75	1.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.58	29.80	0.90
esophagus, adult, pool1	10015-101C6	22.62	39.60	2.44
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	57.23	31.94	2.50
eye - muscle inferior rectus, donor1	10272-104E2	31.39	33.80	7.24
eye - muscle lateral, donor2	10298-104H1	18.94	25.25	4.21
eye - muscle medial, donor2	10299-104H2	25.30	34.23	5.95
eye - muscle superior, donor2	10297-104G9	12.61	35.54	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	13.12	1.46
eye, fetal, donor1	10054-101G9	85.93	104.74	5.34
fibrosarcoma cell line:HT-1080	10758-110E2	23.85	13.08	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.10	28.02	1.42
frontal lobe, adult, pool1	10040-101F4	227.62	159.22	10.04
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.01	13.81	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.53	18.20	1.10
gall bladder, adult	10198-103E9	25.11	39.59	2.17
gamma delta positive T cells, donor1	11937-126A2	215.82	36.51	0.54
gamma delta positive T cells, donor2	11938-126A3	156.49	28.39	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.63	13.94	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	54.54	24.56	0.58
gastric cancer cell line:AZ521	10549-107H9	48.20	23.94	1.97
gastric cancer cell line:GSS	10560-108A2	5.49	7.32	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	53.23	42.49	2.28
giant cell carcinoma cell line:LU65	10487-107B1	15.83	10.90	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	33.73	33.59	3.78
glassy cell carcinoma cell line:HOKUG	10688-109F4	33.17	27.19	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.03	26.60	2.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	26.40	21.91	1.83
glioblastoma cell line:T98G	10485-107A8	14.79	18.87	1.99
glioma cell line:GI-1	10413-106B8	18.45	14.35	1.17
globus pallidus - adult, donor10196	10175-103C4	127.56	84.55	5.83
globus pallidus, adult, donor10252	10161-103A8	108.38	135.96	8.30
globus pallidus, adult, donor10258	10367-105F7	84.89	90.37	10.95
globus pallidus, newborn, donor10223	10364-105F4	85.80	61.82	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	17.13	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	19.20	16.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	14.69	13.31	1.84
hIPS +CCl2, biol_rep2	14384-156C1	18.75	22.86	0.91
hIPS +CCl2, biol_rep3	14385-156C2	12.24	16.10	1.29
hIPS, biol_rep1	14380-156B6	14.37	10.06	0.00
hIPS, biol_rep2	14381-156B7	12.35	10.29	0.69
hIPS, biol_rep3	14382-156B8	195.31	156.69	11.03
hairy cell leukemia cell line:Mo	10712-109I1	68.39	27.30	3.16
heart - mitral valve, adult	10205-103F7	40.96	57.70	2.69
heart - pulmonic valve, adult	10206-103F8	38.96	59.35	5.23
heart - tricuspid valve, adult	10207-103F9	20.82	28.31	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	18.77	27.96	1.84
heart, adult, diseased, donor1	10051-101G6	30.23	67.28	3.83
heart, adult, pool1	10016-101C7	31.51	36.57	1.84
heart, fetal, pool1	10046-101G1	59.04	70.85	4.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	29.31	17.89	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	8.32	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.28	36.35	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	46.73	37.38	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	48.00	36.78	1.92
hepatoma cell line:Li-7	10484-107A7	16.13	8.01	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.98	18.59	2.01
hippocampus - adult, donor10196	10169-103B7	154.25	104.10	6.62
hippocampus, adult, donor10252	10153-102I9	109.60	127.56	7.35
hippocampus, adult, donor10258	10374-105G5	258.44	162.83	14.94
hippocampus, newborn, donor10223	10363-105F3	103.28	72.61	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.38	10.99	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.52	9.82	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.33	12.44	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	7.89	24.25	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	9.55	14.46	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.77	24.30	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.87	32.11	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.10	31.45	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	36.29	26.28	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	50.67	28.42	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.55	24.59	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	20.20	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.91	10.33	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4.91	8.35	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4.36	11.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.23	23.10	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.37	25.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	17.99	24.99	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	33.53	32.59	3.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	37.74	36.38	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.65	40.09	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.11	29.56	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	52.84	28.74	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	52.61	33.78	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.99	11.64	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.28	11.98	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.17	12.66	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	19.72	17.60	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	15.84	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	26.33	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	40.34	32.06	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.18	22.58	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.89	32.07	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	47.81	29.66	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	76.48	53.01	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.74	30.25	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.52	14.49	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.02	6.24	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	5.85	14.63	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.67	16.81	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	71.57	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.24	27.47	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.86	33.93	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.40	28.59	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	31.67	34.88	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	31.03	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	46.18	32.91	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.32	24.25	0.81
immature langerhans cells, donor1	11904-125F5	51.82	20.58	0.48
immature langerhans cells, donor2	11905-125F6	49.90	19.80	1.58
insula, adult, pool1	10039-101F3	251.25	165.23	12.40
keratoacanthoma cell line:HKA-1	10791-110H8	19.18	10.73	0.00
kidney, adult, pool1	10017-101C8	23.23	35.75	2.50
kidney, fetal, pool1	10045-101F9	34.09	62.04	3.75
large cell lung carcinoma cell line:IA-LM	10509-107D5	31.67	17.18	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.00	10.23	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.28	10.09	0.18
left atrium, adult, donor1	10079-102A7	19.07	21.25	2.18
left ventricle, adult, donor1	10078-102A6	21.74	34.38	2.53
leiomyoblastoma cell line:G-402	10721-110A1	13.41	12.86	1.92
leiomyoma cell line:10964C	10569-108B2	34.85	15.81	3.95
leiomyoma cell line:15242A	10570-108B3	33.15	23.37	1.63
leiomyoma cell line:15425	10571-108B4	37.39	19.43	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	31.75	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	11.50	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	57.73	19.24	0.59
liposarcoma cell line:KMLS-1	10782-110G8	19.99	11.87	0.78
liposarcoma cell line:SW 872	10726-110A6	20.71	17.91	0.61
liver, adult, pool1	10018-101C9	25.61	26.25	1.13
liver, fetal, pool1	10086-102B5	29.16	39.51	1.88
locus coeruleus - adult, donor10196	10182-103D2	117.53	92.45	8.02
locus coeruleus, adult, donor10252	10165-103B3	125.49	124.02	11.63
locus coeruleus, adult, donor10258	10375-105G6	138.25	91.69	10.44
locus coeruleus, newborn, donor10223	10362-105F2	81.18	73.19	2.10
lung adenocarcinoma cell line:A549	10499-107C4	12.87	11.76	1.66
lung adenocarcinoma cell line:PC-14	10408-106B3	6.20	12.41	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	32.03	20.96	1.98
lung, adult, pool1	10019-101D1	25.63	51.27	3.90
lung, fetal, donor1	10068-101I5	68.78	138.14	13.41
lung, right lower lobe, adult, donor1	10075-102A3	20.16	29.78	1.37
lymph node, adult, donor1	10077-102A5	35.03	17.99	1.89
lymphangiectasia cell line:DS-1	10727-110A7	24.11	20.60	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	27.92	25.51	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	37.38	0.85
mature adipocyte, donor1	12231-129F8	22.20	26.20	2.22
mature adipocyte, donor2	12232-129F9	29.68	33.20	1.87
mature adipocyte, donor3	12233-129G1	24.65	30.34	1.66
mature adipocyte, donor4	12234-129G2	33.43	35.27	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.03	30.97	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	241.40	161.31	11.28
medial frontal gyrus, adult, donor10252	10150-102I6	153.56	130.94	8.46
medial frontal gyrus, adult, donor10258	10368-105F8	171.55	134.70	10.80
medial frontal gyrus, newborn, donor10223	10352-105E1	113.45	55.02	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	227.98	151.88	16.20
medial temporal gyrus, adult, donor10252	10156-103A3	137.31	128.40	6.37
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	344.80	161.81	28.89
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	545.44	344.49	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	120.96	79.32	5.38
medulla oblongata - adult, donor10196	10174-103C3	84.37	84.37	7.79
medulla oblongata, adult, donor10252	10155-103A2	108.98	124.31	7.12
medulla oblongata, adult, pool1	10038-101F2	135.66	113.54	9.31
medulla oblongata, newborn, donor10223	10361-105F1	70.82	65.27	5.21
medulloblastoma cell line:D283 Med	10838-111E1	68.19	40.52	2.44
medulloblastoma cell line:ONS-76	10759-110E3	23.48	15.90	1.59
melanoma cell line:COLO 679	10514-107E1	33.49	15.09	0.72
melanoma cell line:G-361	10465-106H6	29.59	10.32	0.81
meningioma cell line:HKBMM	10691-109F7	23.52	13.21	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	90.76	74.90	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	78.29	60.14	3.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.02	13.50	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.36	8.54	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.05	9.94	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.81	14.89	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.80	15.41	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.15	11.80	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.45	14.42	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.29	9.32	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	27.46	15.78	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	31.73	15.80	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.30	19.63	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.03	20.75	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.37	17.30	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.88	19.90	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.40	15.11	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	30.91	17.61	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.24	12.83	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	25.54	14.14	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	39.44	19.72	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.96	15.24	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.41	17.59	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.40	25.77	2.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.75	14.59	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.84	17.68	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	13.24	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.88	15.35	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.97	13.09	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.79	16.02	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.95	11.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	20.65	14.89	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	12.58	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	13.90	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.48	14.42	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.74	16.51	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	25.24	17.79	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	11.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.13	13.09	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	11.05	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.32	10.74	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	13.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	20.66	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	15.59	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	10.66	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	9.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	12.44	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	10.49	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	10.93	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.08	15.42	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	13.40	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	8.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	13.80	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	15.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	15.97	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.22	14.67	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	10.33	12.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	16.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.65	14.65	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	13.37	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	13.01	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	20.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	17.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	32.66	21.77	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	20.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	17.17	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.16	25.39	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	34.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	25.34	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.98	19.42	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	31.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.89	26.36	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.21	21.23	1.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.85	18.17	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	29.54	4.07
mesodermal tumor cell line:HIRS-BM	10696-109G3	14.70	10.06	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.25	13.23	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	26.18	29.42	2.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	8.55	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	12.74	9.04	0.31
mesothelioma cell line:Mero-25	10850-111F4	72.85	27.69	1.82
mesothelioma cell line:Mero-41	10851-111F5	12.22	14.67	1.22
mesothelioma cell line:Mero-48a	10852-111F6	29.89	26.13	1.33
mesothelioma cell line:Mero-82	10853-111F7	26.02	18.92	1.05
mesothelioma cell line:Mero-83	10854-111F8	24.68	16.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	16.68	16.18	1.52
mesothelioma cell line:Mero-95	10856-111G1	29.19	36.03	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	27.33	19.22	1.33
mesothelioma cell line:NCI-H226	10846-111E9	27.69	20.09	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	24.94	27.84	2.05
mesothelioma cell line:NCI-H28	10845-111E8	8.14	9.67	1.02
mesothelioma cell line:No36	10857-111G2	22.18	23.49	3.91
mesothelioma cell line:ONE58	10858-111G3	24.39	19.78	0.54
migratory langerhans cells, donor1	11901-125F2	34.55	33.78	2.88
migratory langerhans cells, donor2	11902-125F3	21.25	20.76	1.71
migratory langerhans cells, donor3	11903-125F4	32.13	26.20	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.02	18.28	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.02	7.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.95	15.43	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	56.71	21.88	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	36.77	23.65	0.74
myeloma cell line:PCM6	10474-106I6	22.53	8.10	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	11.67	9.13	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.16	12.36	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.15	12.03	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.63	12.65	0.51
nasal epithelial cells, donor2	12227-129F4	11.59	7.18	0.55
neuroblastoma cell line:CHP-134	10508-107D4	184.51	86.73	3.91
neuroblastoma cell line:NB-1	10539-107G8	118.80	109.82	8.23
neuroblastoma cell line:NBsusSR	10607-108F4	30.79	13.08	0.84
neuroblastoma cell line:NH-12	10555-107I6	99.51	79.76	3.91
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.35	11.39	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	36.11	29.78	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	13.89	13.48	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	5.72	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	20.49	13.84	0.80
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00
neutrophil PMN, donor2	12137-128E4	26.56	39.84	0.00
neutrophil PMN, donor3	12141-128E8	28.41	47.35	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	124.98	68.83	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	55.24	75.25	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.08	20.20	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.21	22.86	1.31
nucleus accumbens, adult, pool1	10037-101F1	217.29	146.05	12.65
occipital cortex - adult, donor10196	10172-103C1	251.37	171.01	20.60
occipital cortex, adult, donor10252	10163-103B1	111.91	113.52	7.78
occipital cortex, newborn, donor10223	10355-105E4	107.36	76.06	5.46
occipital lobe, adult, donor1	10076-102A4	166.36	102.86	8.92
occipital lobe, fetal, donor1	10073-102A1	205.54	88.82	8.58
occipital pole, adult, pool1	10036-101E9	161.63	131.19	9.46
olfactory region, adult	10195-103E6	195.64	127.62	11.46
optic nerve, donor1	10277-104E7	80.04	66.03	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.65	28.59	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	9.20	13.46	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.65	9.82	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.14	15.13	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	16.76	14.11	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	27.10	11.21	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	50.89	16.54	0.85
ovary, adult, pool1	10020-101D2	29.61	53.90	4.98
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.67	7.15	0.37
pancreas, adult, donor1	10049-101G4	29.16	34.80	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.02	6.15	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	24.87	24.70	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.21	10.27	1.32
paracentral gyrus, adult, pool1	10035-101E8	200.98	145.70	11.44
parietal cortex, adult, donor10258	10373-105G4	201.85	106.43	8.81
parietal lobe - adult, donor10196	10171-103B9	189.04	118.50	6.58
parietal lobe, adult, donor10252	10157-103A4	131.97	130.26	9.12
parietal lobe, adult, pool1	10034-101E7	201.88	142.67	11.54
parietal lobe, fetal, donor1	10072-101I9	165.84	89.22	3.88
parietal lobe, newborn, donor10223	10356-105E5	115.15	64.30	6.73
parotid gland, adult	10199-103F1	24.05	34.53	2.47
penis, adult	10200-103F2	27.93	42.43	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	117.33	44.81	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.93	17.63	2.04
pineal gland - adult, donor10196	10179-103C8	338.64	191.57	10.32
pineal gland, adult, donor10252	10160-103A7	378.42	282.49	11.84
pineal gland, adult, donor10258	10377-105G8	258.35	221.98	29.47
pituitary gland - adult, donor10196	10180-103C9	226.64	209.44	11.13
pituitary gland, adult, donor10252	10162-103A9	202.22	250.69	14.59
pituitary gland, adult, donor10258	10378-105G9	158.33	240.90	18.73
placenta, adult, pool1	10021-101D3	16.99	22.79	1.94
plasma cell leukemia cell line:ARH-77	10840-111E3	52.57	32.05	1.72
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.05	9.18	0.62
pons, adult, pool1	10033-101E6	169.47	137.71	12.82
postcentral gyrus, adult, pool1	10032-101E5	201.55	152.12	11.51
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	16.52	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	15.00	13.26	1.89
prostate cancer cell line:PC-3	10439-106E7	25.23	13.25	0.73
prostate, adult, pool1	10022-101D4	27.57	56.23	4.72
putamen, adult, donor10196	10176-103C5	331.91	213.17	15.82
putamen, adult, donor10252	10152-102I8	103.92	100.00	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	203.26	93.98	14.21
putamen, adult, donor10258, tech_rep2	10372-105G3	253.21	135.06	11.11
putamen, newborn, donor10223	10365-105F5	125.19	56.22	0.00
rectal cancer cell line:TT1TKB	10469-106I1	9.60	10.18	0.29
rectum, fetal, donor1	10067-101I4	34.77	55.64	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.63	16.96	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.47	10.36	0.41
retina, adult, pool1	10030-101E3	51.99	89.46	8.15
retinoblastoma cell line:Y79	10475-106I7	51.96	44.69	3.64
rhabdomyosarcoma cell line:KYM-1	10787-110H4	79.92	28.65	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.87	13.22	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	15.91	1.52
salivary acinar cells, donor1	11771-123I7	18.94	15.38	0.97
salivary acinar cells, donor2	11772-123I8	27.26	24.78	0.96
salivary acinar cells, donor3	11773-123I9	19.20	19.20	0.66
salivary gland, adult, pool1	10093-102C3	22.88	36.60	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	34.15	22.43	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.27	18.81	1.53
seminal vesicle, adult	10201-103F3	11.11	43.38	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	7.53	18.22	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.86	19.12	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	21.07	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	28.21	28.48	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	30.62	20.23	1.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.35	11.35	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	19.15	33.34	2.84
skeletal muscle, adult, pool1	10023-101D5	28.07	35.62	2.04
skeletal muscle, fetal, donor1	10066-101I3	6.03	21.11	3.02
skin, adult, donor1	10074-102A2	20.36	47.50	0.00
skin, fetal, donor1	10065-101I2	41.03	43.55	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.35	37.69	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.22	37.19	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	67.08	50.11	4.43
small cell lung carcinoma cell line:LK-2	10541-107H1	31.32	25.38	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	36.51	80.91	5.47
small cell lung carcinoma cell line:WA-hT	10562-108A4	62.76	47.94	2.40
small intestine, adult, pool1	10024-101D6	20.54	31.41	2.27
small intestine, fetal, donor1	10064-101I1	27.27	32.43	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	35.39	2.05
smooth muscle, adult, pool1	10048-101G3	14.22	40.58	3.10
somatostatinoma cell line:QGP-1	10781-110G7	65.67	38.33	0.27
spinal cord - adult, donor10196	10181-103D1	101.17	79.15	8.72
spinal cord, adult, donor10252	10159-103A6	85.95	88.71	6.31
spinal cord, adult, donor10258	10369-105F9	116.91	91.32	9.69
spinal cord, fetal, donor1	10056-101H2	104.89	67.08	6.10
spinal cord, newborn, donor10223	10359-105E8	98.27	70.26	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.99	16.73	1.49
spleen, adult, pool1	10025-101D7	40.64	38.11	1.54
spleen, fetal, pool1	10044-101F8	52.44	61.18	3.18
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	26.60	27.12	2.17
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.04	25.63	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.82	20.97	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	47.30	24.24	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	38.95	34.33	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.76	25.42	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.92	19.46	0.42
stomach, fetal, donor1	10062-101H8	8.54	30.97	2.14
submaxillary gland, adult	10202-103F4	29.62	48.42	1.14
substantia nigra - adult, donor10196	10178-103C7	325.64	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	120.26	105.72	7.27
substantia nigra, adult, donor10258	10371-105G2	183.62	149.49	22.24
substantia nigra, newborn, donor10223	10358-105E7	74.90	55.82	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	38.06	25.68	2.52
temporal lobe, adult, pool1	10031-101E4	188.02	143.43	10.60
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	169.52	106.84	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	195.15	105.05	7.03
tenocyte, donor1	11763-123H8	48.18	26.88	1.75
tenocyte, donor2	11765-123I1	45.02	23.27	2.29
tenocyte, donor3	11768-123I4	37.44	23.72	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.72	15.98	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	10.79	10.79	0.62
teratocarcinoma cell line:PA-1	10807-111A6	3.10	8.37	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	9.65	5.97	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.07	34.41	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	18.98	9.92	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.91	11.73	1.30
testis, adult, pool1	10026-101D8	53.69	65.28	6.76
testis, adult, pool2	10096-102C6	116.83	106.91	15.79
thalamus - adult, donor10196	10168-103B6	151.25	117.02	7.73
thalamus, adult, donor10252	10154-103A1	122.84	135.03	6.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	283.29	229.40	16.94
thalamus, adult, donor10258, tech_rep2	10370-105G1	79.55	84.65	5.27
thalamus, newborn, donor10223	10366-105F6	75.94	74.22	2.30
throat, adult	10209-103G2	23.47	46.44	3.25
throat, fetal, donor1	10061-101H7	30.47	39.31	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	37.16	33.39	2.19
thymus, adult, pool1	10027-101D9	88.08	46.13	2.19
thymus, fetal, pool1	10043-101F7	88.94	58.39	2.29
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.08	13.56	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	23.19	21.79	1.54
thyroid, adult, pool1	10028-101E1	38.35	70.54	4.67
thyroid, fetal, donor1	10060-101H6	31.11	42.98	5.01
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	18.48	0.00
tongue, adult	10203-103F5	24.19	29.77	3.95
tongue, fetal, donor1	10059-101H5	33.10	39.02	1.97
tonsil, adult, pool1	10047-101G2	61.01	47.58	2.10
trachea, adult, pool1	10029-101E2	27.08	34.27	2.21
trachea, fetal, donor1	10058-101H4	36.93	30.39	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.55	16.65	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	11.75	10.64	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.18	16.92	1.88
tridermal teratoma cell line:HGRT	10694-109G1	15.22	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	22.52	14.81	0.42
umbilical cord, fetal, donor1	10057-101H3	18.78	45.90	8.35
uterus, adult, pool1	10100-102D1	25.08	68.08	5.63
uterus, fetal, donor1	10055-101H1	23.04	43.51	8.70
vagina, adult	10204-103F6	25.20	53.63	7.11
vein, adult	10191-103E2	47.13	48.88	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	42.46	17.62	1.07